{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:54:11Z","timestamp":1792522451685,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Kocaeli University","award":["TDK-2021-2626"],"award-info":[{"award-number":["TDK-2021-2626"]}]},{"name":"Scientific Research Projects Coordination Unit of Kocaeli University","award":["TDK-2021-2626"],"award-info":[{"award-number":["TDK-2021-2626"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton\u2019s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human Wharton\u2019s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers (\n                      <jats:italic>Ki67<\/jats:italic>\n                      ,\n                      <jats:italic>Pcna<\/jats:italic>\n                      ) and antioxidant genes (\n                      <jats:italic>Nrf2<\/jats:italic>\n                      ,\n                      <jats:italic>Sod1<\/jats:italic>\n                      ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes (\n                      <jats:italic>Star<\/jats:italic>\n                      ,\n                      <jats:italic>Gdf9<\/jats:italic>\n                      ,\n                      <jats:italic>Bmp15<\/jats:italic>\n                      ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Quercetin-loaded EVs derived from Wharton\u2019s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-025-01838-5","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:41:23Z","timestamp":1761558083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-569X","authenticated-orcid":false,"given":"Zeynep Ece Utkan","family":"Korun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-4939","authenticated-orcid":false,"given":"Zehra Seda","family":"Halbutogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-0261","authenticated-orcid":false,"given":"Yusufhan","family":"Yazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0501-1679","authenticated-orcid":false,"given":"Selenay","family":"Furat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-1849","authenticated-orcid":false,"given":"Candan","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8723-9417","authenticated-orcid":false,"given":"Ahmet","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-2905","authenticated-orcid":false,"given":"Tugba","family":"Koldankaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5939-5295","authenticated-orcid":false,"given":"Serap","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8459-2538","authenticated-orcid":false,"given":"Erkut","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae065","volume":"2024","author":"N Panay","year":"2024","unstructured":"Panay N, Anderson RA, Bennie A, Cedars M, Davies M, Ee C, et al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024:hoae065.","journal-title":"Hum Reprod Open"},{"key":"1838_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2517514","volume":"2016","author":"D Song","year":"2016","unstructured":"Song D, Zhong Y, Qian C, Zou Q, Ou J, Shi Y, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. BioMed Res Int. 2016;2016:2517514.","journal-title":"BioMed Res Int"},{"key":"1838_CR3","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/cncr.26403","volume":"118","author":"JM Letourneau","year":"2012","unstructured":"Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2012;118:1933\u20139.","journal-title":"Cancer"},{"key":"1838_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/0002-9343(71)90341-X","volume":"50","author":"JJ Miller III","year":"1971","unstructured":"Miller JJ III, Williams GF, Leissring JC. Multiple late complications of therapy with cyclophosphamide, including ovarian destruction. Am J Med. 1971;50:530\u20135.","journal-title":"Am J Med"},{"key":"1838_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0890-6238(92)90005-E","volume":"6","author":"DR Plowchalk","year":"1992","unstructured":"Plowchalk DR, Meadows MJ, Mattison DR. Reproductive toxicity of cyclophosphamide in the C57BL\/6 N mouse: 2. Effects on uterine structure and function. Reprod Toxicol. 1992;6:423\u20139.","journal-title":"Reprod Toxicol"},{"key":"1838_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/REP-12-0121","volume":"144","author":"I Ben-Aharon","year":"2012","unstructured":"Ben-Aharon I, Shalgi R. What lies behind chemotherapy-induced ovarian toxicity? Reproduction. 2012;144:153\u201363.","journal-title":"Reproduction"},{"key":"1838_CR7","doi-asserted-by":"publisher","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and Burnout; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5:185ra62.","journal-title":"Sci Transl Med"},{"key":"1838_CR8","doi-asserted-by":"crossref","unstructured":"Practice C. on G. Hormone therapy in primary ovarian insufficiency. Obstetrics and gynecology. 2017;129:E134\u201341.","DOI":"10.1097\/AOG.0000000000002044"},{"key":"1838_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ogc.2014.10.004","volume":"42","author":"E Kovanci","year":"2015","unstructured":"Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015;42:153\u201361.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1838_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biopha.2018.03.056","volume":"102","author":"G Sheikhansari","year":"2018","unstructured":"Sheikhansari G, Aghebati-Maleki L, Nouri M, Jadidi-Niaragh F, Yousefi M. Current approaches for the treatment of premature ovarian failure with stem cell therapy. Biomed Pharmacother. 2018;102:254\u201362.","journal-title":"Biomed Pharmacother"},{"key":"1838_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01131-3","volume":"16","author":"L Mirzaeian","year":"2023","unstructured":"Mirzaeian L, Eivazkhani F, Saber M, Moini A, Esfandiari F, Valojerdi MR, et al. In-vivo oogenesis of oogonial and mesenchymal stem cells seeded in transplanted ovarian extracellular matrix. J Ovarian Res. 2023;16:56. https:\/\/doi.org\/10.1186\/s13048-023-01131-3.","journal-title":"J Ovarian Res"},{"key":"1838_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/labinvest.2012.167","volume":"93","author":"Y Takehara","year":"2013","unstructured":"Takehara Y, Yabuuchi A, Ezoe K, Kuroda T, Yamadera R, Sano C, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest. 2013;93:181\u201393.","journal-title":"Lab Invest"},{"key":"1838_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12015-022-10493-y","volume":"19","author":"A Umer","year":"2023","unstructured":"Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure. Stem Cell Rev Rep. 2023;19:651\u201366.","journal-title":"Stem Cell Rev Rep"},{"key":"1838_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1211070","volume":"10","author":"X Wang","year":"2023","unstructured":"Wang X, Li T, Bai X, Zhu Y, Zhang M, Wang L. Therapeutic prospect on umbilical cord mesenchymal stem cells in animal model with primary ovarian insufficiency: a meta-analysis. Front Med. 2023;10:1211070.","journal-title":"Front Med"},{"key":"1838_CR15","doi-asserted-by":"publisher","first-page":"e106538","DOI":"10.1371\/journal.pone.0106538","volume":"9","author":"G-Y Xiao","year":"2014","unstructured":"Xiao G-Y, Liu I-H, Cheng C-C, Chang C-C, Lee Y-H, Cheng WT-K, et al. Amniotic fluid stem cells prevent follicle Atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy. PLoS ONE. 2014;9:e106538.","journal-title":"PLoS ONE"},{"key":"1838_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8837654","author":"D Rady","year":"2020","unstructured":"Rady D, Abbass M, El-Rashidy AA, El Moshy S, Radwan IA, D\u00f6rfer CE, et al. Mesenchymal stem\/progenitor cells: the prospect of human clinical translation. Stem Cells Int. 2020. https:\/\/doi.org\/10.1155\/2020\/8837654.","journal-title":"Stem Cells Int"},{"key":"1838_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04992","author":"M Zolfaghar","year":"2020","unstructured":"Zolfaghar M, Mirzaeian L, Beiki B, Naji T, Moini A, Eftekhari-Yazdi P, et al. Wharton\u2019s jelly derived mesenchymal stem cells differentiate into oocyte like cells in vitro by follicular fluid and cumulus cells conditioned medium. Heliyon. 2020. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04992.","journal-title":"Heliyon"},{"key":"1838_CR18","first-page":"407","volume":"16","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Sun J, Huang Y, Bu S, Guo Y, Gu T, et al. Human amniotic epithelial cell-derived exosomes restore ovarian function by transferring microRNAs against apoptosis. Mol Ther. 2019;16:407\u201318.","journal-title":"Mol Ther"},{"key":"1838_CR19","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.4161\/cc.10.18.17638","volume":"10","author":"W Zhu","year":"2011","unstructured":"Zhu W, Huang L, Li Y, Qian H, Shan X, Yan Y, et al. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle. 2011;10:3198\u2013207. https:\/\/doi.org\/10.4161\/cc.10.18.17638.","journal-title":"Cell Cycle"},{"key":"1838_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.joca.2012.06.002","volume":"20","author":"M Horie","year":"2012","unstructured":"Horie M, Choi H, Lee RH, Reger RL, Ylostalo J, Muneta T, et al. Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian Hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage. 2012;20:1197\u2013207.","journal-title":"Osteoarthritis Cartilage"},{"key":"1838_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"key":"1838_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2014.08.026","volume":"474","author":"C Su","year":"2014","unstructured":"Su C, Li H, Shi Y, Wang G, Liu L, Zhao L, et al. Carboxymethyl-\u03b2-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Int J Pharm. 2014;474:202\u201311.","journal-title":"Int J Pharm"},{"key":"1838_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01201-6","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024. https:\/\/doi.org\/10.1038\/s12276-024-01201-6.","journal-title":"Exp Mol Med"},{"key":"1838_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.11.002","author":"S Shankar","year":"2013","unstructured":"Shankar S, Kumar D, Srivastava RK. Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition. Pharmacol Ther. 2013. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.11.002.","journal-title":"Pharmacol Ther"},{"key":"1838_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2005.08.005","volume":"521","author":"JC Chen","year":"2005","unstructured":"Chen JC, Ho FM, Chao PDL, Chen CP, Jeng KCG, Hsu HB, et al. Inhibition of iNOS gene expression by Quercetin is mediated by the Inhibition of I\u03baB kinase, nuclear factor-kappa B and STAT1, and depends on Heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol. 2005;521:9\u201320.","journal-title":"Eur J Pharmacol"},{"key":"1838_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-009-0148-z","author":"A Scheepens","year":"2010","unstructured":"Scheepens A, Tan K, Paxton JW. Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr. 2010. https:\/\/doi.org\/10.1007\/s12263-009-0148-z.","journal-title":"Genes Nutr"},{"key":"1838_CR27","doi-asserted-by":"crossref","unstructured":"Terao J. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochem Pharmacol. 2017;139:15\u201323.","DOI":"10.1016\/j.bcp.2017.03.021"},{"key":"1838_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114068","author":"SR Alizadeh","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA, Elsevier Masson s.r.l. Quercetin derivatives: drug design, development, and biological activities, a review. Eur J Med Chem. 2022. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114068.","journal-title":"Eur J Med Chem"},{"key":"1838_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuroscience.2024.05.028","volume":"552","author":"C Yang","year":"2024","unstructured":"Yang C, Xu T, Lu Y, Liu J, Chen C, Wang H, et al. Quercetin-loaded human umbilical cord mesenchymal stem cell-derived sevs for spinal cord injury recovery. Neuroscience. 2024;552:14\u201328.","journal-title":"Neuroscience"},{"key":"1838_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","volume":"27","author":"Y Qi","year":"2020","unstructured":"Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020;27:745\u201355.","journal-title":"Drug Deliv"},{"key":"1838_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1040027","author":"A Raghav","year":"2022","unstructured":"Raghav A, Giri R, Agarwal S, Kala S, Jeong GB. Protective role of engineered extracellular vesicles loaded Quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: a prospective review. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1040027.","journal-title":"Front Immunol"},{"key":"1838_CR32","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.2147\/IJN.S422416","volume":"18","author":"M Zhuang","year":"2023","unstructured":"Zhuang M, Rao L, Chen Y, Xiao S, Xia H, Yang J, et al. Controlled SPION-Exosomes loaded with Quercetin preserves pancreatic beta cell survival and function in type 2 diabetes mellitus. Int J Nanomed. 2023;18:5733\u201348.","journal-title":"Int J Nanomed"},{"key":"1838_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02259-6","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnol. 2024. https:\/\/doi.org\/10.1186\/s12951-023-02259-6.","journal-title":"J Nanobiotechnol"},{"key":"1838_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release. 2015;207:18\u201330.","journal-title":"J Control Release"},{"key":"1838_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5966\/sctm.2011-0011","volume":"1","author":"DP Lennon","year":"2012","unstructured":"Lennon DP, Schluchter MD, Caplan AI. The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells. Stem Cells Transl Med. 2012;1:279\u201388.","journal-title":"Stem Cells Transl Med"},{"key":"1838_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5114\/ceji.2024.143726","volume":"49","author":"C \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk C, Halbuto\u011fullari ZS. Immune regulation is more effective in the U937 inflammation model with mesenchymal stem cell extracellular vesicles stimulated by pro-inflammatory cytokines. Cent Eur J Immunol. 2024;49:282\u201399.","journal-title":"Cent Eur J Immunol"},{"key":"1838_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02198-0","volume":"40","author":"E Sovunjov","year":"2023","unstructured":"Sovunjov E, Halbuto\u011fullar\u0131 ZS, Gacar G, \u00d6zt\u00fcrk A, Duruksu G, Yaz\u0131r Y. Examining the effect of activated cytotoxic (CD8+) T-cell exosomes to the lung cancer. Med Oncol. 2023;40:359.","journal-title":"Med Oncol"},{"key":"1838_CR38","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.apsb.2021.12.015","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wang L, Liu X, Bai Y, Wu R, Li X, et al. Milk-derived exosomes exhibit versatile effects for improved oral drug delivery. Acta Pharm Sin B. 2022;12:2029\u201342.","journal-title":"Acta Pharm Sin B"},{"key":"1838_CR39","doi-asserted-by":"crossref","unstructured":"Zhang T, Yan DW, Yang Y, Ma A, Li L, Wang Z et al. The comparison of animal models for premature ovarian failure established by several different source of inducers. Regul Toxicol Pharmacol. 2016;81:223\u201332. Available from: https:\/\/api.semanticscholar.org\/CorpusID:40744612","DOI":"10.1016\/j.yrtph.2016.09.002"},{"key":"1838_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10616-009-9206-z","volume":"59","author":"R Mukai","year":"2009","unstructured":"Mukai R, Shirai Y, Saito N, Yoshida K, Ashida H. Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope. Cytotechnology. 2009;59:177\u201382.","journal-title":"Cytotechnology"},{"key":"1838_CR41","first-page":"e4447","volume":"12","author":"J Santelices","year":"2022","unstructured":"Santelices J, Ou M, Hui WW, Maegawa GHB, Edelmann MJ. Fluorescent labeling of small extracellular vesicles (EVs) isolated from conditioned media. Bio Protoc. 2022;12:e4447\u20134447.","journal-title":"Bio Protoc"},{"key":"1838_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01080-3","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao Y, Miao C, Yang L, Wang R, Chen B, et al. Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells. J Ovarian Res. 2022. https:\/\/doi.org\/10.1186\/s13048-022-01080-3.","journal-title":"J Ovarian Res"},{"key":"1838_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09513590.2021.1878133","volume":"37","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang L, Li Y, Yin Z, Feng Y, Ji Y. Human umbilical cord mesenchymal stem cells (hUCMSCs) promotes the recovery of ovarian function in a rat model of premature ovarian failure (POF). Gynecol Endocrinol. 2021;37:353\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1838_CR44","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/stem.3204","volume":"38","author":"C Ding","year":"2020","unstructured":"Ding C, Zhu L, Shen H, Lu J, Zou Q, Huang C, et al. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells. 2020;38:1137\u201348.","journal-title":"Stem Cells"},{"key":"1838_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1327-5","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, et al. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice. Stem Cell Res Ther. 2019;10:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"1838_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/09513590.2017.1393661","volume":"34","author":"R Bao","year":"2018","unstructured":"Bao R, Xu P, Wang Y, Wang J, Xiao L, Li G, et al. Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy. Gynecol Endocrinol. 2018;34:320\u20136.","journal-title":"Gynecol Endocrinol"},{"key":"1838_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-017-9765-x","volume":"14","author":"Z Fazeli","year":"2018","unstructured":"Fazeli Z, Abedindo A, Omrani MD, Ghaderian SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Rev Rep. 2018;14:1\u201312.","journal-title":"Stem Cell Rev Rep"},{"key":"1838_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0461-6","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang Y, Yang T, Li J, Yang X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017;8:1\u201314.","journal-title":"Stem Cell Res Ther"},{"key":"1838_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcyt.2014.08.009","volume":"17","author":"N Watson","year":"2015","unstructured":"Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan MC, et al. Discarded wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 2015;17:18\u201324.","journal-title":"Cytotherapy"},{"key":"1838_CR50","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2019.46.1.1","volume":"46","author":"SY Yoon","year":"2019","unstructured":"Yoon SY. Mesenchymal stem cells for restoration of ovarian function. Clin Exp Reprod Med. 2019;46:1.","journal-title":"Clin Exp Reprod Med"},{"key":"1838_CR51","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tice.2016.05.001","volume":"48","author":"AK Elfayomy","year":"2016","unstructured":"Elfayomy AK, Almasry SM, El-Tarhouny SA, Eldomiaty MA. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: possible direct and indirect effects. Tissue Cell. 2016;48:370\u201382.","journal-title":"Tissue Cell"},{"key":"1838_CR52","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.yexcr.2010.05.009","volume":"316","author":"AM Hocking","year":"2010","unstructured":"Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res. 2010;316:2213\u20139.","journal-title":"Exp Cell Res"},{"key":"1838_CR53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/bcpt.13696","volume":"130","author":"S Zheng","year":"2022","unstructured":"Zheng S, Ma M, Chen Y, Li M. Effects of quercetin on ovarian function and regulation of the ovarian PI3K\/Akt\/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide-induced premature ovarian failure. Basic Clin Pharmacol Toxicol. 2022;130:240\u201353.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1838_CR54","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5103067","volume":"51","author":"CY Eren","year":"2024","unstructured":"Eren CY, Gurer HG, Gursoy OO, Yilmaz O, Tunc E, Aypak SU, et al. The effect of Quercetin on ovary functions in rats with cyclophosphamide induced ovary damage. Clin Exp Obstet Gynecol. 2024;51:67.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1838_CR55","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1177\/0960327119865588","volume":"38","author":"MA Elkady","year":"2019","unstructured":"Elkady MA, Shalaby S, Fathi F, El-Mandouh S. Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice. Hum Exp Toxicol. 2019;38:1283\u201395.","journal-title":"Hum Exp Toxicol"},{"key":"1838_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.actbio.2019.01.065","volume":"87","author":"Y-C Kuo","year":"2019","unstructured":"Kuo Y-C, Chen C-L, Rajesh R. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration. Acta Biomater. 2019;87:207\u201322.","journal-title":"Acta Biomater"},{"key":"1838_CR57","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14653240802035926","volume":"10","author":"X Fu","year":"2008","unstructured":"Fu X, He Y, Xie C, Liu W. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy. 2008;10:353\u201363.","journal-title":"Cytotherapy"},{"key":"1838_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1933719117699705","volume":"25","author":"SA Mohamed","year":"2018","unstructured":"Mohamed SA, Shalaby SM, Abdelaziz M, Brakta S, Hill WD, Ismail N, et al. Human mesenchymal stem cells partially reverse infertility in chemotherapy-induced ovarian failure. Reprod Sci. 2018;25:51\u201363.","journal-title":"Reprod Sci"},{"key":"1838_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311151","volume":"24","author":"H-S Park","year":"2023","unstructured":"Park H-S, Cetin E, Siblini H, Seok J, Alkelani H, Alkhrait S, et al. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles to treat PCOS. Int J Mol Sci. 2023;24:11151.","journal-title":"Int J Mol Sci"},{"key":"1838_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02786-x","volume":"7","author":"L Sun","year":"2017","unstructured":"Sun L, Li D, Song K, Wei J, Yao S, Li Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep. 2017;7:2552.","journal-title":"Sci Rep"},{"key":"1838_CR61","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s10815-018-1268-4","volume":"35","author":"A Sanfins","year":"2018","unstructured":"Sanfins A, Rodrigues P, Albertini DF. GDF-9 and BMP-15 direct the follicle symphony. J Assist Reprod Genet. 2018;35:1741\u201350.","journal-title":"J Assist Reprod Genet"},{"key":"1838_CR62","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/MCB.26.3.940-954.2006","volume":"26","author":"X Hu","year":"2006","unstructured":"Hu X, Roberts JR, Apopa PL, Kan YW, Ma Q. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol. 2006;26:940\u201354.","journal-title":"Mol Cell Biol"},{"key":"1838_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1095\/biolreprod.111.092999","volume":"86","author":"Y Noda","year":"2012","unstructured":"Noda Y, Ota K, Shirasawa T, Shimizu T. Copper\/zinc superoxide dismutase insufficiency impairs progesterone secretion and fertility in female mice. Biol Reprod. 2012;86:11\u20136.","journal-title":"Biol Reprod"},{"key":"1838_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0953-7","volume":"9","author":"B Huang","year":"2018","unstructured":"Huang B, Lu J, Ding C, Zou Q, Wang W, Li H. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther. 2018;9:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"1838_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1136-x","volume":"10","author":"L Ling","year":"2019","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10:46. https:\/\/doi.org\/10.1186\/s13287-019-1136-x.","journal-title":"Stem Cell Res Ther"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01838-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:09:13Z","timestamp":1761563353000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01838-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01838-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7086896\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Experiments Local Ethics Committee of Kocaeli University (approval number: KO\u00dc-HAYDEK 7\/3-2020) and was conducted in accordance with institutional ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}